From 2021 to 2023, there was an increase in prescription rates of a sodium-glucose cotransporter-2 inhibitor (SGLT2i) for ...
Heart failure is responsible for 13 percent of deaths worldwide, and half of patients die within 5 years. New therapies are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback